In Alzheimer’s disease and Parkinson’s disease, accumulation of β-amyloid, tau, and α-synuclein respectively, occurs in the OFB early in the disease when olfactory symptoms are present (Kovács et al., 2001; Braak et al., 2003; Zapiec et al., 2017). Here, SNCA is linked to Alzheimer disease.